Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Advances in systemic sclerosis and related fibrotic and vascular conditions

Therapeutic targets in systemic sclerosis

Christopher P Denton

Arthritis Research & Therapy 2007, 9(Suppl 2):S6 doi:10.1186/ar2190

Accesses  

  • Last 30 days: 47 accesses
  • Last 365 days: 540 accesses
  • All time: 5260 accesses